News

Food and Drug Administration commissioner Marty Makary has chosen former biotech executive George Tidmarsh as the agency’s ...
Tidmarsh, who has founded and served as CEO of several biotech companies, will lead a crucial FDA division that reviews the ...
Notorious Ecuadoran drug trafficker Adolfo Macias, alias "Fito," pleaded not guilty to narcotics charges in a US court Monday ...
Note that some links may require registration or subscription. A 61-year-old man who last week was pulled into an MRI machine ...
The U.S. Food and Drug Administration said on Monday it has appointed George Tidmarsh, a seasoned biotech executive and ...
Buried within the One Big Beautiful Bill Act is a provision that could improve or even save the lives of the 30 million ...
U.S. Food and Drug Administration commissioner Marty Makary has chosen former biotech executive George Tidmarsh as the ...
The U.S. Food and Drug Administration ( FDA) has placed an immediate clinical hold on Sarepta Therapeutics' investigational ...
The new approval will help Merck make a return on its $3.9 billion investment in acquiring SpringWorks, which has operated as ...
Tidmarsh, an adjunct professor at Stanford’s medical school, brings decades of industry experience to the table. Serving as ...
An analysis from the Congressional Budget Office warns that cuts to the National Institutes of Health and FDA drug reviews could significantly reduce the number of new medications reaching the U.S.